Milk fermented by Lactobacillus casei CRL431 modifies cytokine profiles associated to different stages of breast cancer development in mice
- 10 July 2019
- journal article
- research article
- Published by Brill in Beneficial Microbes
- Vol. 10 (6) , 689-698
Abstract
Breast cancer is one of the leading causes of death worldwide. It is recognised that immune system influences its promotion, progression, and metastasis, as well as their responsiveness to therapies. Previously, it was reported that milk fermented by Lactobacillus casei CRL431 decreased tumour growth and metastasis in a mouse breast cancer model, through the modulation of the host immune response. The aim of the present work was to analyse the systemic immune response induced by the administration of probiotic fermented milk (PFM) at different stages of cancer development, evaluating cytokines produced by splenocytes stimulated in vitro with 4T1 tumour cells, or its conditioned medium (CM). Groups of healthy mice and mice bearing 4T1 tumour or suffering metastasis after tumour surgery were studied. Results showed that at the early stages, PFM maintained pro-inflammatory response associated to the delay or the inhibition of tumour growth. PFM administration to mice bearing tumour maintained an important inflammatory response; however, in contrast to the milk group, this response was regulated to avoid exacerbation of inflammation. In the metastasis model, the benefits of PFM were associated to avoid the immunosuppression associated to high interleukin-10 levels. In conclusion, as cancer cells induce modifications of the immune response to favour their own growth at each stage of cancer development, PFM administration stimulated different profile of cytokines to respond to these modifications and fight against cancer cells.Keywords
This publication has 24 references indexed in Scilit:
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- Cytokine patterns in patients with cancer: a systematic reviewThe Lancet Oncology, 2013
- The role of intratumoral and systemic IL-6 in breast cancerBreast Cancer Research and Treatment, 2013
- T-helper-1-cell cytokines drive cancer into senescenceNature, 2013
- Role of interleukin-10 in breast cancerBreast Cancer Research and Treatment, 2011
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and PromotionScience, 2011
- Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent modelsJournal of Immunological Methods, 2008
- Rejection of Metastatic 4T1 Breast Cancer by Attenuation of Treg Cells in Combination With Immune StimulationMolecular Therapy, 2007
- Interferon-γ and Cancer ImmunoeditingImmunologic Research, 2005
- Serum levels of interleukin-10 in patients affected by breast cancerImmunology Letters, 1996